Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss and polycystic ovary syndrome are often linked.

A new treatment plan helps manage folliculitis decalvans effectively.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Five monthly sessions of minoxidil-dutasteride-copper peptide tattooing significantly improve hair regrowth in men with androgenetic alopecia.

Low-dose oral minoxidil improved hair growth in a woman with short anagen syndrome.

Mothers with atopic dermatitis have higher risks of pregnancy complications and their children are more likely to develop certain health issues.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

The conference highlighted new treatments and research in pediatric skin conditions, emphasizing collaboration and innovation.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Researchers suggest using a standard question and 5-point scale to measure patient satisfaction with acne scar treatments.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Nanocarriers can improve skin drug delivery but face challenges in clinical use.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

People with early-onset hair loss have higher risk of heart issues, so early screening is important.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Nanoparticles effectively deliver water-insoluble drugs to hair follicles, stimulating hair growth without irritating the skin.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

High doses of minoxidil can harm marmoset hearts and kidneys, possibly affecting humans similarly.